Categories
Mangalam Drugs And Organics Limited — Board Meeting, 14-05-2026: Outcome of Board Meeting
14-05-2026 · 06:27 pm
Mangalam Drugs & Organics' board approved Q4 & FY26 audited consolidated financial results, reporting a net loss of ₹44.40 Cr for the year. A merger scheme with two subsidiaries is scheduled for a tribunal hearing on June 02, 2026.
No comments yet. Be the first to comment!